Literature DB >> 15304644

The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition.

Stéphane Sidobre1, Kirsten J L Hammond, Lise Bénazet-Sidobre, Sergei D Maltsev, Stewart K Richardson, Rachel M Ndonye, Amy R Howell, Teruyuki Sakai, Gurdyal S Besra, Steven A Porcelli, Mitchell Kronenberg.   

Abstract

Natural killer (NK) T cells with an invariant Valpha14 rearrangement (Valpha14i) are the largest population of lipid antigen-specific T lymphocytes identified in animals. They react to the glycolipid alpha-galactosyl ceramide (alpha-GalCer) presented by CD1d, and they may have important regulatory functions. It was previously shown that the Valpha14i T cell antigen receptor (TCR) has a high affinity for the alpha-GalCer/CD1d complex, driven by a long half-life (t(1/2)). Although this result could have reflected the unique attributes of alpha-GalCer, using several related glycolipid compounds, we show here that the threshold for full activation of Valpha14i NKT cells by these glycosphingolipids requires a relatively high-affinity TCR interaction with a long t(1/2). Furthermore, our data are consistent with the view that the mechanism of recognition of these compounds presented by CD1d to the Valpha14i NKT cell TCR is likely to fit a lock-and-key model. Overall, these findings emphasize the distinct properties of glycosphingolipid antigen recognition by Valpha14i NKT cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304644      PMCID: PMC514465          DOI: 10.1073/pnas.0404632101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Les liaisons dangereuses.

Authors:  B Malissen
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

Review 2.  NKT cells: facts, functions and fallacies.

Authors:  D I Godfrey; K J Hammond; L D Poulton; M J Smyth; A G Baxter
Journal:  Immunol Today       Date:  2000-11

3.  NKT cells and tumor immunity--a double-edged sword.

Authors:  M J Smyth; D I Godfrey
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

Review 4.  T cell receptor binding kinetics and special role of Valpha in T cell development and activation.

Authors:  N R Gascoigne; S M Alam; C M Lin; M V McGuire; S Marine; N Niederberger; S Redpath; B C Sim; P J Travers; P Yachi; M A Zal; T Zal
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  CD1d-restricted NKT cells: an interstrain comparison.

Authors:  K J Hammond; D G Pellicci; L D Poulton; O V Naidenko; A A Scalzo; A G Baxter; D I Godfrey
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 6.  CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity.

Authors:  K Benlagha; A Bendelac
Journal:  Semin Immunol       Date:  2000-12       Impact factor: 11.130

7.  Structural requirements for antigen presentation by mouse CD1.

Authors:  N Burdin; L Brossay; M Degano; H Iijima; M Gui; I A Wilson; M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.

Authors:  K Miyamoto; S Miyake; T Yamamura
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

9.  Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules.

Authors:  O V Naidenko; J K Maher; W A Ernst; T Sakai; R L Modlin; M Kronenberg
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

10.  Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.

Authors:  J L Matsuda; O V Naidenko; L Gapin; T Nakayama; M Taniguchi; C R Wang; Y Koezuka; M Kronenberg
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

View more
  41 in total

1.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.

Authors:  Dirk M Zajonc; Carlos Cantu; Jochen Mattner; Dapeng Zhou; Paul B Savage; Albert Bendelac; Ian A Wilson; Luc Teyton
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

Review 2.  Harnessing invariant NKT cells in vaccination strategies.

Authors:  Vincenzo Cerundolo; Jonathan D Silk; S Hajar Masri; Mariolina Salio
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

3.  Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand.

Authors:  Jeong-Ju Park; Ji Hyung Lee; Subhash C Ghosh; Gabriel Bricard; Manjunatha M Venkataswamy; Steven A Porcelli; Sung-Kee Chung
Journal:  Bioorg Med Chem Lett       Date:  2008-06-14       Impact factor: 2.823

4.  4"-O-Alkylated α-Galactosylceramide Analogues as iNKT-Cell Antigens: Synthetic, Biological, and Structural Studies.

Authors:  Jonas Janssens; Aruna Bitra; Jing Wang; Tine Decruy; Koen Venken; Johan van der Eycken; Dirk Elewaut; Dirk M Zajonc; Serge van Calenbergh
Journal:  ChemMedChem       Date:  2018-12-17       Impact factor: 3.466

5.  Are fat NKT cells born that way?

Authors:  Joshua A Vieth; Derek B Sant'Angelo
Journal:  Cell Mol Immunol       Date:  2017-07-03       Impact factor: 11.530

Review 6.  T cells specific for lipid antigens.

Authors:  Lucia Mori; Gennaro De Libero
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

7.  Regulatory roles for NKT cell ligands in environmentally induced autoimmunity.

Authors:  Jaya Vas; Jochen Mattner; Stewart Richardson; Rachel Ndonye; John P Gaughan; Amy Howell; Marc Monestier
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.

Authors:  Douglass Wu; Dirk M Zajonc; Masakazu Fujio; Barbara A Sullivan; Yuki Kinjo; Mitchell Kronenberg; Ian A Wilson; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

9.  The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode.

Authors:  Yali Li; Enrico Girardi; Jing Wang; Esther Dawen Yu; Gavin F Painter; Mitchell Kronenberg; Dirk M Zajonc
Journal:  J Exp Med       Date:  2010-10-04       Impact factor: 14.307

10.  Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.

Authors:  Barbara A Sullivan; Niranjana A Nagarajan; Gerhard Wingender; Jing Wang; Iain Scott; Moriya Tsuji; Richard W Franck; Steven A Porcelli; Dirk M Zajonc; Mitchell Kronenberg
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.